Close



Feb 20, 2024 04:01PM
Nov 6, 2023 04:01PM
Aug 8, 2023 04:01PM
May 9, 2023 04:01PM
Feb 21, 2023 04:01PM
Jan 10, 2023 05:15PM
Nov 8, 2022 04:01PM HALOZYME REPORTS THIRD QUARTER 2022 FINANCIAL AND OPERATING RESULTS
Aug 16, 2022 05:56AM
Aug 15, 2022 10:32PM
Aug 15, 2022 07:01AM
Aug 15, 2022 07:00AM
Aug 9, 2022 04:01PM
May 12, 2022 08:03AM
May 12, 2022 08:00AM Hart-Scott-Rodino Waiting Period Expires for Halozyme's Acquisition of Antares Pharma
May 10, 2022 04:01PM
Apr 26, 2022 08:00AM
Apr 13, 2022 06:00AM
Apr 13, 2022 06:00AM
Feb 22, 2022 04:01PM
Jan 10, 2022 08:00AM
Dec 9, 2021 04:01PM Halozyme Therapeutics (HALO) approves $750M share repurchase program
Dec 9, 2021 04:01PM
Nov 2, 2021 04:01PM
Aug 9, 2021 04:01PM
May 10, 2021 04:01PM
Feb 24, 2021 10:41PM
Feb 23, 2021 04:10PM
Feb 23, 2021 04:10PM Halozyme Therapeutics, Inc. Announces Proposed Offering of $500 Million of Convertible Senior Notes due 2027
Feb 23, 2021 04:01PM
Jan 11, 2021 09:14AM
Jan 11, 2021 08:00AM
Nov 2, 2020 04:01PM
Aug 10, 2020 04:01PM
May 11, 2020 04:01PM
Feb 24, 2020 04:23PM Halozyme Therapeutics (HALO) Announces CFO Transition
Feb 24, 2020 04:02PM
Feb 24, 2020 04:01PM
Jan 14, 2020 08:07AM
Jan 14, 2020 08:00AM
Nov 12, 2019 04:01PM
Nov 4, 2019 07:03AM
Nov 4, 2019 07:00AM Halozyme Announces Actions To Focus Strategy On ENHANZE® Drug Delivery Technology
Jun 5, 2015 09:00AM
Oct 3, 2014 09:31AM
Oct 2, 2014 06:04PM
May 17, 2013 09:31AM

77,774 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All